Fairview Pharmacy Services LLC
Fairview Pharmacy Services LLC was paid $4.13M by Medicaid between Jan 2018 and Dec 2024, across 25 billing codes. Its largest line is J2315, Injection, naltrexone, depot form, 1 mg — 24% of everything it billed.
SHOREVIEW, MN 55126
Next to other Durable Medical Equipment & Medical Supplies providers in Minnesota
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,803 | $280K | |
| 2019 | 12,318 | $1.15M | |
| 2020 | 10,814 | $840K | |
| 2021 | 9,742 | $500K | |
| 2022 | 12,960 | $375K | |
| 2023 | 13,879 | $545K | |
| 2024incomplete | 9,072 | $443K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J2315 | Injection, naltrexone, depot form, 1 mg | 24% | 868 | 764 | $991K |
| A9276 | Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable medical equipment interstitial continuous glucose monitoring system, one unit = 1 day supply | 22% | 4,587 | 3,721 | $929K |
| A4230 | Infusion set for external insulin pump, non needle cannula type | 12% | 4,293 | 3,690 | $507K |
| K0553 | Supply allowance for therapeutic continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service | 8.4% | 8,058 | 6,656 | $348K |
| A9277 | Transmitter; external, for use with non-durable medical equipment interstitial continuous glucose monitoring system | 8.0% | 2,061 | 1,541 | $329K |
| A4239 | Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service | 7.6% | 6,451 | 6,113 | $314K |
| A9274 | External ambulatory insulin delivery system, disposable, each, includes all supplies and accessories | 4.9% | 414 | 375 | $204K |
| A4232 | Syringe with needle for external insulin pump, sterile, 3 cc | 2.5% | 2,970 | 2,525 | $105K |
| J7518 | Mycophenolic acid, oral, 180 mg | 2.3% | 2,304 | 2,070 | $95K |
| J7507 | Tacrolimus, immediate release, oral, 1 mg | 1.8% | 9,056 | 6,408 | $74K |
| A9278 | Receiver (monitor); external, for use with non-durable medical equipment interstitial continuous glucose monitoring system | 1.4% | 256 | 240 | $57K |
| Q0511 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period | <1% | 11,601 | 10,491 | $35K |
13 more codes
| Q0512 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period | <1% | 13,383 | $31K |
| A4225 | Supplies for external insulin infusion pump, syringe type cartridge, sterile, each | <1% | 1,432 | $30K |
| J7517 | Mycophenolate mofetil, oral, 250 mg | <1% | 5,984 | $28K |
| A4224 | Supplies for maintenance of insulin infusion catheter, per week | <1% | 209 | $20K |
| J7515 | Cyclosporine, oral, 25 mg | <1% | 619 | $10K |
| K0554 | Receiver (monitor), dedicated, for use with therapeutic glucose continuous monitor system | <1% | 100 | $10K |
| E2103 | Non-adjunctive, non-implanted continuous glucose monitor or receiver | <1% | 163 | $8K |
| J7639 | Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 13 | $7K |
| Q0513 | Pharmacy dispensing fee for inhalation drug(s); per 30 days | <1% | 374 | $2K |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 3,313 | $229.88 |
| A4253 | Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips | <1% | 16 | $89.88 |
| Q0510 | Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant | <1% | 33 | $40.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 30 | $34.29 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Fairview Pharmacy Services LLC | Shoreview, MN | $19.96M |
| Fairview Pharmacy Services, LLC | Saint Paul, MN | $231K |
| Fairview Pharmacy Services LLC | Minneapolis, MN | $98K |
| Fairview Pharmacy Services LLC | Eagan, MN | $63K |
| Fairview Pharmacy Services LLC | Saint Paul, MN | $61K |
| Fairview Pharmacy Services LLC | Saint Paul, MN | $47K |
| Fairview Pharmacy Services LLC | Minneapolis, MN | $39K |
| Fairview Pharmacy Services LLC | Apple Valley, MN | $37K |
| Fairview Pharmacy Services LLC | Saint Paul, MN | $34K |
| Fairview Pharmacy Services, LLC | Duluth, MN | $33K |
| Fairview Pharmacy Service LLC | Minneapolis, MN | $25K |
| Fairview Pharmacy Services, LLC | Saint Paul, MN | $18K |
| Fairview Pharmacy Services | Minneapolis, MN | $14K |
| Fairview Pharmacy Services, LLC | Maplewood, MN | $11K |
| Fairview Pharmacy Services LLC | Minneapolis, MN | $10K |
| Fairview Pharmacy Services LLC | Minneapolis, MN | $9K |
| Fairview Pharmacy Services LLC | Minneapolis, MN | $9K |
| Fairview Pharmacy Services, LLC | Princeton, MN | $7K |
| Fairview Pharmacy Services LLC | Saint Paul, MN | $3K |
| Fairview Pharmacy Services LLC | Edina, MN | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.